Diagnosis: Morphology, Flow Cytometry, Cytogenetics, Molecular Testing, and Risk-Stratification
Experts discuss how to diagnosis AML. Faculty: AnneMarie W. Block, PhD, FACMG Director, Clinical Cytogenetics Laboratory Division of Diagnostic Hematology ...
American Society of Hematology
Dr. Patnaik on Activity of SL-401 in Chronic Myelomonocytic Leukemia
Mrinal Patnaik, MBBS, hematologist, Mayo Clinic, discusses the encouraging results seen in a phase II trial evaluating the activity of SL-401 in patients with ...
OncLiveTV
The Patients' Journey Toward a Diagnosis of Myeloproliferative Neoplasms (MPNs)
Ellen Ritchie, MD, Associate Professor of Clinical Medicine, Weill Cornell Medical College, discusses the patients' journey toward a diagnosis of ...
CheckRare
Talking myeloproliferative neoplasms (MPN) with Dr Lynette Chee
The Leukaemia Foundation presents an informational video about myeloproliferative neoplasms (MPN), with expert guest Dr Lynette Chee.
Leukaemia Foundation
Detecting CML (Chronic Myeloid Leukemia) w/ Digital PCR | #LabChat
When it comes to quantifying molecular targets in chronic myeloid leukemia (CML) samples, real-time PCR has long been trusted as the gold standard. However ...
Thermo Fisher Scientific
Leumeta - A New Leukemia/Lymphoma Test
While conventional tests look for cancer cells in bone marrow or, in certain cases, peripheral blood, LEUMETA cancer assays track genetic components of ...
Quest Diagnostics
Ask the Expert: MDS & Leukemia
Blood cancers like myelodysplastic syndrome (MDS) can be particularly challenging to diagnose and treat. Learn more during our chat with physician Yazan ...
UTSWMed
What is leukemia || classification of leukemia || Lab diagnosis of leukemia step by step
This is video regarding leukemia: Topic- 1.what is leukemia & cause of leukemia 2. Classification of leukemia 3. Difference between acute and chronic leukemia ...
Medical LABORATORY Tuition
Chronic myeloid leukaemia: diagnosis and management
Chronic myeloid leukaemia is a common malignancy worldwide. We have come a long way from the limited treatment options and survival in this condition.
Internal Medicine
Ask an MPN Expert: Tracking and Living With MPNs
Oncology Nurse Educator Paul Larson responds to questions from the MPN community about tracking symptoms and other issues of myeloproliferative ...
Voices of MPN
Leukocyte Alkaline Phosphatase “LAP score”
Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/ - With Picmonic, get your life back by studying less and remembering more.
Medicosis Perfectionalis
Bone marrow inflammation leads to leukemia
Like a line of falling dominos, a cascade of molecular events in the bone marrow produces high levels of inflammation that disrupt normal blood formation and ...
Indiana University School of Medicine
Treatment of Acute Myeloid Leukemia (AML)
Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/ - With Picmonic, get your life back by studying less and remembering more.
Medicosis Perfectionalis
Dr Ruben Mesa How Progress in Blood Cancer Helps MPN Patients San Meteo 2016
MPN Advocacy and Education
Blood Cancer 101 | Closer to a Cure Community Lecture Series
UCLA oncologists Gary Schiller, MD and Patricia Young, MD, and social worker Rebecca Pittenger, LCSW, give an overview of blood cancers, what causes ...
UCLA Health
The Leukemia & Lymphoma Society Roundtable - Innovation in Research: Blood Cancers and Beyond
Beat AML: Progress in Treating Acute Myeloid #Leukemia at the 60th American Society Hematology Meeting & Expo.
Leukemia & Lymphoma Society
Blood Cancer 101: What You Need to Know | UCLA Blood & Bone Marrow Transplant
Join UCLA oncologists, Gary Schiller, MD, and Patricia Young, MD, for an overview of blood cancers, what causes them, symptoms and diagnosis.
UCLA Health
Molecular Typing for Leukemias & Lymphomas: Aid in Therapies
This topic was presented at the Leukemia Research Foundation's Treatment Options for Blood Cancer Patients Conference on Saturday, May 20, 2017 by Dr.
Leukemia Research Foundation
Hemostasis: Lesson 9 - Thrombocytosis
An overview of thrombocytosis, including etiologies and a focused discussion on essential thrombocythemia and polycythemia vera.
Strong Medicine
2013 Annual Hematology Meeting: CLL - Upfront therapy
Drs. Ravandi-Kashani, Czuczman, Steensma, Cortes, Anderson, and Brown comprise the faculty for this compelling group of Best of the Day interviews with Dr.
ImedexCME
When and How to Use Iron Chelation Therapy in MDS
Filmed on location in Zagreb, Croatia during the European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes from 24-26 April 2015, this ...
ImedexCME
Survival Data for Patients Younger Than 60 With Primary Myleofibrosis
Dr. Ayalew Tefferi, Professor of Hematology and Medicine at Mayo Clinic in Rochester, MN, discusses the findings of the largest ever study with the most mature ...
Mayo Proceedings
My approach to MDS management
In this presentation from the 2017 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Rami Komrokji discusses his approach to the ...
ImedexCME
CML and pregnancy: Patient and partner considerations
In this presentation from the Great Debates & Updates in Hematologic Malignancies 2018 conference, Dr. Marlise R. Luskin discusses CML patient and partner ...
ImedexCME
Discussion on Current Issues in Myeloproliferative Neoplasms (MPN)
Filmed at SOHO, September 2015, Dr. Swami P. Iyer, MD conducts a Discussion on Current Issues in Myeloproliferative Neoplasms (MPN) with Srdan ...
Oncology.TV
Treatment Options for Myeloproliferative Neoplasms (MPNs)
Ellen Ritchie, MD, Associate Professor of Clinical Medicine, Weill Cornell Medical College, discusses the available treatment options for Myeloproliferative ...
CheckRare
Coronavirus and chronic myeloid leukaemia (CML) with Professor Steve O'Brien
VIDEO RECORDED LIVE on 23/4/2020. INFORMATION CORRECT AS OF THIS DATE. In the video we are joined by Professor Steve O'Brien and CML patient ...
Leukaemia Care
Beyond JAK2 Inhibitors: New Targets and New Agents
As recent discoveries have the potential to change the paradigm of how MPN and MDS are diagnosed and treated, it is imperative that healthcare professionals ...
ImedexCME
Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival
Dr. S. Vincent Rajkumar, Professor of Medicine in the Division of Hematology at Mayo Clinic in Rochester, MN, illuminates the results an article appearing in the ...
Mayo Proceedings
Adverse Events During Ruxolitinib Treatment Discontinuation in Patients with Myelofibrosis
Dr. Animesh Pardanani, Assistant Professor of Medicine and Consultant in the Division of Hematology at Mayo Clinic in Rochester, MN, Discusses his article, ...
Mayo Proceedings
AML Fab classification and staining (myeloblastic leukemia)
HIII welcome to my channel....all the best to all medicos and para medical staff,who dedicate their lives for improving health of people...!!!
Medical World
My approach to MF management
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Claire Harrison outlines her approach ...
ImedexCME
MDS, Aplastic Anemia, and PNH in 2012
In recent years, better data has been collected on how many people have various bone marrow failure diseases and on what populations may be at risk for ...
AAMDSIF
Debate: What is the best approach for relapsed T cell lymphoma? - AlloSCT
The continued evolution and refinement of strategies for disease diagnosis, risk assessment, therapeutic intervention and disease management have provided ...
ImedexCME
Assessment of novel treatment options for patients with PV
Polycythemia vera is the most common of the myeloproliferative neoplasms characterized by elevated hematocrit, splenomegaly and increased thrombotic risk.
ImedexCME
My approach to MF management
In this presentation from the 2017 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Olatoyosi Odenike discusses her approach ...
ImedexCME
Therapy for “Early MF”: Pros and cons
Clinical outcomes and quality of life in patients with MPN and MDS continue to be enhanced as cytogenetic analysis and novel therapeutic strategies are ...
ImedexCME
Long-term follow-up: AML17 trial of ATO and ATRA vs the standard of care in APL
Alan K. Burnett, MD, FRCP from Cardiff University, Cardiff, UK discusses the findings of the AML17 randomized controlled Phase III trial comparing ...
VJHemOnc – Video Journal of Hematological Oncology
Debate: Optimal approach for the management of CLL patients with del(17p) - Novel Agents
The continued evolution and refinement of strategies for disease diagnosis, risk assessment, therapeutic intervention and disease management have provided ...
ImedexCME
Topical challenges in the management of ET
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Jiří Schwarz discusses challenges in ...
ImedexCME
Mayo Clinic Proceedings April 2019 Issue Summary
Dr. Karl Nath, Editor in Chief of Mayo Clinic Proceedings, discusses the Editor's Choice and Highlighted articles in the April 2019 issue.
Mayo Proceedings
Myelofibrosis for Patients
Ruben A. Mesa, M.D., FACP and Robyn M. Scherber, M.D., MPH of UT Health San Antonio MD Anderson Cancer Center discuss the diagnosis, presenting ...
UT Health San Antonio MD Anderson Cancer Center
